TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 49 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2015. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,058,000 | -41.0% | 200,000 | 0.0% | 0.20% | +19.5% |
| Q2 2015 | $1,794,000 | +41.9% | 200,000 | 0.0% | 0.17% | +42.0% |
| Q1 2015 | $1,264,000 | +8.2% | 200,000 | 0.0% | 0.12% | +6.2% |
| Q4 2014 | $1,168,000 | -14.7% | 200,000 | 0.0% | 0.11% | -20.6% |
| Q3 2014 | $1,370,000 | -52.3% | 200,000 | 0.0% | 0.14% | -42.7% |
| Q2 2014 | $2,870,000 | +37.8% | 200,000 | 0.0% | 0.25% | +44.7% |
| Q1 2014 | $2,082,000 | – | 200,000 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 370,000 | $1,602,000 | 0.67% |